Drug Topics
SEPTEMBER 28, 2022
The future of independent pharmacy requires the combination of what makes independent pharmacy special and the digital landscape found elsewhere in retail.
PharmaVoice
SEPTEMBER 28, 2022
Swiss-based Stalicla is banking on an AI-driven precision medicine discovery platform to deliver needed therapies in the autism space.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Topics
SEPTEMBER 28, 2022
A recent review article lists six other JAK inhibitors that might be used as treatments for vitiligo in addition to ruxolitinib, the active ingredient in recently approved Opzelura.
Pharmacy Times
SEPTEMBER 28, 2022
Investigators combine research discovery with technological development to determine whether the role of genomics in nephrology should remain with subspecialists or be integrated into general nephrology.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Drug Topics
SEPTEMBER 28, 2022
However, researchers found that only a small percentage of plans use available real-world evidence studies and economic evaluations in their coverage policies.
Pharmacy Times
SEPTEMBER 28, 2022
Pharmacists play an important role in the recovery journey for patients who decide medication assisted treatment is right for them.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
STAT
SEPTEMBER 28, 2022
BROWNSVILLE, Texas — Gladys Maestre is on a scouting mission. The Alzheimer’s disease researcher is driving through Southmost, a Mexican American neighborhood just north of looming sections of the border wall and a checkpoint that leads to Mexico. She passes barking dogs and “no trespassing” signs, but doesn’t see a single person outside, despite the comfortable stuffed recliners, refrigerators, and shade canopies that furnish many yards.
Drug Topics
SEPTEMBER 28, 2022
Key opinion leaders discuss disparities across varying patient demographics concerning access to vaccines.
STAT
SEPTEMBER 28, 2022
HARLINGEN, Texas — Here in the Rio Grande Valley almost everyone knows, or cares for, someone with dementia. It’s not a surprise. The region has some of the nation’s highest rates of the disease. But what’s less appreciated is the enormity of the burden carried by the mostly Mexican American caregivers. In a culture where caregiving is a family affair, it’s almost unthinkable for children and spouses to place loved ones in nursing facilities or ask for outside
pharmaphorum
SEPTEMBER 28, 2022
The US FDA’s Center for Devices and Radiological Health (CDRH) dropped a bevy of new digital health guidances and reports today and yesterday, providing some long-awaited clarity and peeks into the agency’s future plans. . The Pre-Cert pilot report. The push started yesterday with the 31-page key findings report from the FDA Pre-Certification Program pilot.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
PharmaVoice
SEPTEMBER 28, 2022
The company's CEO, Kabir Nath, discusses potential roadblocks to commecialization that await its psilocybin treatment for depression.
Pharmacy Times
SEPTEMBER 28, 2022
On this week's episode, host Joanna speaks with Charlie Conway, PhD, chief scientific officer at Biohaven Pharmaceuticals about migraine function, care, and treatment.
European Pharmaceutical Review
SEPTEMBER 28, 2022
In a study published in the Microchemical Journal , investigators outlined the development and validation of a HPLC-MS/MS (high-performance liquid chromatography-mass spectrometry) for the determination and quantification of N -nitrosodimethylamine (NDMA) in olmesartan medoxomil. The method was able to detect, separate and quantify NDMA in the active pharmaceutical ingredient (API), manufactured tablets and marketed tablets.
Pharmacy Times
SEPTEMBER 28, 2022
We spoke with Brandon Dyson, PharmD, BCOP, co-founder of TL;DR Pharmacy, to hear about this unique resource for pharmacy students.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
STAT
SEPTEMBER 28, 2022
The Food and Drug Administration on Tuesday published a list of artificial intelligence tools that should be regulated as medical devices, in some cases appearing to expand its oversight of previously unregulated software products. In a new final guidance for industry, the agency specified that tools designed to warn caregivers of sepsis, a life-threatening complication of infection, should come under regulatory review.
Pharmacy Times
SEPTEMBER 28, 2022
Study finds that 13% of all heart-related emergency department visits were related to essential hypertension.
STAT
SEPTEMBER 28, 2022
A new study suggests there may be a link between aluminum used in vaccines that are given to young children in the first two years of life and the risk of developing asthma before age 5. The findings are preliminary and both the authors and others who have studied the data urge caution in the interpretation of the results. Based on the findings, the possible association needs to be further explored, said the authors, who nonetheless are worried that in an era of rampant vaccine misinformation an
Pharmacy Times
SEPTEMBER 28, 2022
There were approximately 250,000 new cases of prostate cancer identified in the United States in 2021, which is considered approximately 13% of all cancer cases.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
STAT
SEPTEMBER 28, 2022
The Food and Drug Administration’s approach to reviewing updates to software products is far slower than consumers have come to expect for apps, a top agency official acknowledged Tuesday. Unlike many commonly used apps, which are frequently updated as developers fix bugs and add new features, updates to regulated digital health products often require a lengthy review.
European Pharmaceutical Review
SEPTEMBER 28, 2022
The United States Pharmacopeia (USP) has opened a 90-day review period for their proposed Cannabis Species Inflorescence monograph in the Herbal Medicines Compendium (HMC), a laboratory quality standards testing reference used internationally. The proposed cannabis monograph provides scientifically validated methods, information on physical reference standards and acceptance criteria to establish the identity of cannabis chemotypes and content of cannabinoids and terpenes, as well as setting l
STAT
SEPTEMBER 28, 2022
An investigational Alzheimer’s disease treatment from Biogen and Eisai slowed the rate of cognitive decline by 27% in a clinical trial, the companies said Tuesday, meeting the goals of a closely tracked study and strengthening the drug’s case for approval as early as January. The positive result is welcome news for the millions of people living with Alzheimer’s and a big win for Eisai and Biogen, giving the companies a potential blockbuster product in the intravenous medicin
Drug Store News
SEPTEMBER 28, 2022
Ahold Delhaize’s supervisory board will propose the reappointment of Frans Muller as company president, CEO and member of the management board.
STAT
SEPTEMBER 28, 2022
You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and medicine. Sign up here to receive it in your inbox. Everything you need to know about health care in this week’s government funding bill. Republicans prevailed in the fight over user fee legislation to fund the FDA, my colleague Rachel Cohrs reported last night.
Drug Store News
SEPTEMBER 28, 2022
NACDS is engaging in the White House Conference on Hunger, Nutrition, and Health with commitments and recommendations, as well as hosting a satellite event to extend its reach.
STAT
SEPTEMBER 28, 2022
You’re reading the web edition of STAT Health Tech, our guide to how tech is transforming the life sciences. Sign up to get this newsletter delivered in your inbox every Tuesday and Thursday. Google’s wearables plan takes shape. If you’ve been wondering how the tech titan planned to blend Fitbit with its analytics business, Mario’s got you covered.
Drug Store News
SEPTEMBER 28, 2022
The webinar featured a discussion on how pharmacies can successfully execute the program.
pharmaphorum
SEPTEMBER 28, 2022
Martin Mendoza, PhD, director of health equity and health science policy for the All of Us Research Program at the National Institutes of Health (NIH), tells pharmaphorum about the programme and how it will accelerate research for the benefit of all patients. NIH’s All of Us is building an extensive, diverse biomedical dataset to learn how biology, lifestyle, and environment affect one’s health, and to accelerate research and improve personalised medicine options. “The All of U
Drug Store News
SEPTEMBER 28, 2022
Effaclar Salicylic Acid Acne Treatment Serum is formulated to clear acne blemishes while also working to help prevent new ones.
STAT
SEPTEMBER 28, 2022
Good morning, one and all. Damian here, filling in for Ed Silverman once more. Here as always is a smattering of items to get your day started. And do let us know if you hear anything interesting out there. … Senate Democrats conceded to passing a crucial Food and Drug Administration funding bill without any extra policy reforms attached, STAT tells us.
Drug Store News
SEPTEMBER 28, 2022
Sitagliptin is an active ingredient in Januvia, Janumet and Janumet XR.
PharmExec
SEPTEMBER 28, 2022
Wednesday, September 28, 2022, 11 am ET Join this webinar to hear industry thought leaders discuss issues that impede cell and gene therapy development. They will cover new approaches for expanding viral vector manufacturing capacity with appropriate quality, share recommendations for streamlining clinical trial design and process development, explore opportunities for adapting the regulatory framework for cell and gene therapy technologies, and examine innovative pricing and contracting models.
Drug Store News
SEPTEMBER 28, 2022
Purple, the newest character and spokescandy, is making her debut with a music single and video, titled “I’m Just Gonna Be Me.
Outsourcing Pharma
SEPTEMBER 28, 2022
Outsourcing-Pharma caught up with Esther Mahillo, VP of Operational Strategy and Feasibility, Precision for Medicine to talk about advancements in patient enrollment in oncology and rare disease clinical trials.
Expert insights. Personalized for you.
466 
Let's personalize your content